Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd QNTM


Primary Symbol: C.QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by JAKPUG4LIFEon Aug 30, 2024 12:22pm
378 Views
Post# 36202974

Re: $12.80 US TP

Re: $12.80 US TP
Primary Risks 

The Company has experienced substantial losses since its establishment and might continue to face financial deficits in the foreseeable future. 

A whole lot of big names since inception what, 6 or so yrs ago has been there go to. 2 huge splits of  201/1 and 65/1. A name change cannot hide this. The executive team and the big names have made millions upon millions off the backs of retail investors who are down over 99 percent now.  The high compensation and bonuses continue. Do your DD. Financials don't lie


Post by lscfaon Aug 30, 2024 12:01pm
16 Views 
Post# 36202935

$12.80 US TP


<< Previous
Bullboard Posts
Next >>